The TP53, NOTCH1, SF3B1, and BIRC3 among these mutations have been established as prognostic factors for the course of CLL, and it is recommended to incorporate them into CLL prognostic scales [24,25]. This evidence concerns the gene TP53 and B-cell chronic lymphocytic leukemia.